BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: BP-C1|DRUG: Placebo
Sponsor: Meabco A/S
Collaborators: Meddoc|Norwegian University of Life Sciences